BerandaE2XA34 • BVMF
add
Exact Sciences Corp
Tutup sebelumnya
R$32,45
Rentang hari
R$32,45 - R$32,45
Rentang tahun
R$22,74 - R$42,10
Kapitalisasi pasar
9,91Â M USD
Volume Rata-Rata
544,00
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 708,66Â jt | 12,78% |
Biaya operasional | 531,08Â jt | -0,43% |
Laba bersih | -38,24Â jt | -4.915,62% |
Margin laba bersih | -5,40 | -4.253,85% |
Penghasilan per saham | -0,13 | 59,97% |
EBITDA | 36,28Â jt | 270,41% |
Tarif pajak efektif | -2,16% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 1,02Â M | 39,04% |
Total aset | 6,75Â M | 5,10% |
Total liabilitas | 3,54Â M | 7,23% |
Total ekuitas | 3,21 M | — |
Saham yang beredar | 185,08 jt | — |
Harga terhadap nilai buku | 1,87 | — |
Tingkat pengembalian aset | -0,69% | — |
Tingkat pengembalian modal | -0,77% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -38,24Â jt | -4.915,62% |
Kas dari operasi | 138,72Â jt | 469,43% |
Kas dari investasi | -81,72Â jt | -147,86% |
Kas dari pembiayaan | -226,00Â rb | -345,65% |
Perubahan kas bersih | 58,65Â jt | 701,48% |
Arus kas bebas | 107,80Â jt | 982,44% |
Tentang
Exact Sciences Corp. is an American molecular diagnostics company based in Madison, Wisconsin specializing in the detection of early stage cancers. The company's initial focus was on the early detection and prevention of colorectal cancer; in 2014 it launched Cologuard, the first stool DNA test for colorectal cancer. Since then Exact Sciences has grown its product portfolio to encompass other screening and precision oncological tests for other types of cancer. Wikipedia
CEO
Didirikan
1 Jan 1995
Kantor pusat
Situs
Karyawan
6.550
